Prognostic Impact of β-Blocker Dose After Acute Myocardial Infarction

Background: The differential prognostic impact of β-blocker dose after acute myocardial infarction (AMI) has been under debate. The current study sought to compare clinical outcome after AMI according to β-blocker dose using the Korea Acute Myocardial Infarction Registry-National Institutes of Healt...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation Journal 2019/01/25, Vol.83(2), pp.410-417
Hauptverfasser:	Hwang, Doyeon, Lee, Joo Myung, Kim, Hyun Kuk, Choi, Ki Hong, Rhee, Tae-Min, Park, Jonghanne, Park, Taek Kyu, Yang, Jeong Hoon, Song, Young Bin, Choi, Jin-Ho, Hahn, Joo-Yong, Choi, Seung-Hyuk, Koo, Bon-Kwon, Kim, Young Jo, Chae, Shung-Chull, Cho, Myeong Chan, Kim, Chong Jin, Gwon, Hyeon-Cheol, Jeong, Myung Ho, Kim, Hyo-Soo, Investigators, The KAMIR
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute myocardial infarction Adrenergic beta-Antagonists - administration & dosage Adrenergic beta-Antagonists - pharmacology Aged Beta-blocker Death Female Humans Male Middle Aged Myocardial Infarction - diagnosis Myocardial Infarction - drug therapy Myocardial Infarction - mortality National Institutes of Health (U.S.) Outcome Prognosis Registries Republic of Korea Survival Analysis United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background: The differential prognostic impact of β-blocker dose after acute myocardial infarction (AMI) has been under debate. The current study sought to compare clinical outcome after AMI according to β-blocker dose using the Korea Acute Myocardial Infarction Registry-National Institutes of Health (KAMIR-NIH). Methods and Results: Of the total population of 13,104 consecutive AMI patients enrolled in the KAMIR-NIH, the current study analyzed 11,909 patients. These patients were classified into 3 groups (no β-blocker; low-dose [
ISSN:	1346-9843 1347-4820
DOI:	10.1253/circj.CJ-18-0662